Author: Beeler, Judy A.; Eichelberger, Maryna C.
Title: Influenza and respiratory syncytial virus (RSV) vaccines for infants: Safety, immunogenicity, and efficacy Cord-id: cotgutwd Document date: 2012_12_13
ID: cotgutwd
Snippet: Respiratory viral infections in infants and young children frequently cause illness that can easily progress to hospitalization and death. There are currently no licensed vaccines to prevent respiratory viral disease in children younger than 6 months, reflecting safety concerns and the difficulty in inducing effective immune responses in infants. This review discusses vaccines that have been developed, or are currently being developed, against influenza and respiratory syncytial virus, with a fo
Document: Respiratory viral infections in infants and young children frequently cause illness that can easily progress to hospitalization and death. There are currently no licensed vaccines to prevent respiratory viral disease in children younger than 6 months, reflecting safety concerns and the difficulty in inducing effective immune responses in infants. This review discusses vaccines that have been developed, or are currently being developed, against influenza and respiratory syncytial virus, with a focus on studies performed to demonstrate their safety and efficacy, and the impact of immunologic immaturity and maternal antibodies on the infant response to vaccines.
Search related documents:
Co phrase search for related documents- acute illness and additional information: 1, 2, 3
- acute illness and additional testing: 1, 2, 3, 4, 5, 6
- adaptive immune response and adjuvant activity: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date